top of page
AAO 2026: ANTERIOR SEGMENT SHOWCASE
Moderators: Julie M. Schallhorn, MD, MS, Program Committee and Kendall Donaldson, MD, MS, Program Committee
Panel: Zaina Al-Mohtaseb, MD, Director, Research, Whitsett Vision Group
Room: 243-245
Start | Company | Presenter |
|---|---|---|
1:00 PM | Introduction | Julie Schallhorn, MD, MS |
1:03 PM | Cavalry Biosciences | Preston Klassen, MD, MHS, CEO |
1:08 PM | Claris Biotherapeutics, Inc. | Stephen Brady, President & CEO |
1:13 PM | Epion Therapeutics | Michael D. Webb, President & CEO |
1:18 PM | Discussion | |
1:24 PM | Oculis Holding AG | Riad Sherif, MD, CEO |
1:29 PM | OKYO Pharma | Robert J. Dempsey, CEO |
1:34 PM | EyeDura Therapeutics | Srini Venkatesh, PhD, CEO |
1:39 PM | Discussion | |
1:45 PM | TECLens | Madhu Ayyagari, PhD, MBA, CEO |
1:50 PM | iVeena | Bali Ambati, MD, PhD, MBA, Founder & Chief Medical Officer |
1:55 PM | Lento Bio, Inc. | Kris Barnes, PhD, CEO |
2:00 PM | Discussion | |
2:06 PM | ForSight VISION6 | Ayman Naseri, MD, President & CMO |
2:11 PM | Drop Mate, Inc | Vikram Shankar, MD, MPH, Co-founder & CEO |
2:16 PM | Theialife | Tom Ruggia, President & CEO |
2:21 PM | Discussion | |
2:27 PM | Conclusion | Kendall Donaldson, MD, MS |
2:30 PM | End of Session |
Anchor 1
bottom of page